Patent · US Active

N-(benzimimdazol-2-yl)-cyclopropane carboxamides as lysophosphatidic acid antagonists

US8912202B2 · kind B2 · utility

10Cited by

0References

19Claims

0Family size

Assignee

Merck Patent GmbH · DE

Inventors

Wolfgang Staehle · Ingelheim am Rhein, DE
Melanie Schultz · Darmstadt, DE
Kai Schiemann · Darmstadt, DE

Key dates

Filing date	Jul 7, 2012
Grant date	Dec 16, 2014
Priority date	—
Expiry date	Jul 7, 2032

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC07D471/04
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

The invention provides novel substituted cyclopropane carboxamide compounds according to Formula (I), their manufacture and use for the treatment of proliferative or inflammatory diseases, such as cancer, fibrosis or arthritis.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.